Drug treatments to reduce excitotoxicity in vivo: A potential for α2-adrenoceptor antagonists?

Amino Acids

Volumn 19, Issue 1, 2000, Pages 239-252

  Martel, J C ^a   Chopin, P ^a   Colpaert, F ^a   Marien, M ^a  

^a INSTITUT DE RECHERCHE PIERRE FABRE   (France)

Author keywords

2 Adrenoceptor antagonists; Amino acids; Excitotoxicity; Intracerebral microdialysis; Neuroprotection; Quinolinic acid

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; DIZOCILPINE; EFAROXAN; IDAZOXAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DRUG MECHANISM; IN VIVO STUDY; LOCUS CERULEUS; MICRODIALYSIS; NERVE DEGENERATION; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT;

ADRENERGIC ALPHA-ANTAGONISTS; ANIMAL; BEHAVIOR, ANIMAL; BENZOFURANS; CORPUS STRIATUM; IDAZOXAN; IMIDAZOLES; MALE; MICRODIALYSIS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, ALPHA-2;

ANIMALIA;

EID: 0033795915     PISSN: 09394451     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007260070055     Document Type: Article

References (57)

1. Alternative excitotoxic hypothesis
2. Ultrastructural localization of β-adrenergic receptor-like immunoreactivity in the cortex and neostriatum of rat brain
3. An investigation of the mechanisms of delayed neurodegeneration caused by direct injection of quinolinate into the rat striatum in vivo
4. Role of excitotoxicity in human neurological disease
5. Do defects in mitochondrial energy metabolism underlie the pathology of neurodegenerative diseases?
6. 2-Adrenergic agonists reduce glutamate release and glutamate receptor-mediated calcium changes in hippocampal slices during hypoxia
7. Locus coeruleus lesions potentiate neurotoxic effects of MPTP in dopaminergic neurons of the substantia nigra
8. Lesioning of the locus coeruelus system aggravates ischemic damage in the rat brain
9. Molecular pharmacology of adrenergic receptors and their cellular localization in brain cells in culture
10. Noradrenaline antagonizes and ouabain potentiates the effects of N-methyl-D-aspartate on rat cerebellar cyclic GMP production
11. Excitotoxic cell death
12. Pharmacological characteristics of tremor, rigidity and hypokinesia induced by reserpine in the rat
13. Noradrenergic mechanisms in Parkinson's disease: A theory
14. Noradrenergic regulation of delayed neuronal death after transient forebrain ischemia
15. Presynaptic α-2 adrenoceptors play a major role in the effects of Idazoxan on cortical noradrenaline release (as measured by in vivo dialysis) in the rat
16. 2-adrenoceptors
17. Molecular profile of reactive astrocytes - Implication for their role in neurologic disease
18. Functional evidence that BDNF is an anterograde neuronal trophic factor in the CNS
19. Mechanisms of noradrenergic modulation of physical therapy: Effects of functional recovery after cortical injury
20. Norepinephrine suppresses inducible nitric oxide synthase activity in rat astroglial cultures
21. A rapid radiochemical method for the determination of choline acetyltransferase
22. 2-Adrenoceptors and I2 sites in the mammalian central nervous system
23. Dopamine-glutamate interactions in the striatum: Behaviourally relevant modification of excitotoxicity by dopamine receptor-mediated mechanisms
24. Potential impact of drugs on poststroke motor recovery
25. Reactive astrocyte formation in vivo is regulated by noradrenergic axons
26. Cerebral ischemia and the central noradrenergic system in the rat
27. Postischemic administration of idazoxan, an α-2 adrenergic receptor antagonist, decreases neuronal damage in the rat brain
28. 2-adrenoceptor antagonist idazoxan: Influence of time of administration and possible mechanisms of action
29. Adrenergic receptor regulation of amino acid neurotransmitter uptake in astrocytes
30. Autonomic control of neuronal-astrocytic interactions, regulating metabolic activities and ion fluxes in the CNS
31. Image analyser assisted morphometry of the locus coeruleus in Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis
32. 2-adreceptors in the rat brain
33. Physiological actions of taurine
34. Recovery of function is associated with increased spine density in cortical pyramidal cells after frontal lesions and/or noradrenaline depletion in neonatal rats
35. Noradrenaline depletion exacerbates MPTP-induced striatal dopamine loss in mice
36. 2-adrenoceptor antagonists, (+)-efaroxan and (±)-idazoxan, against quinolinic acid-induced lesions of the rat striatum
37. Effect of locus coeruleus lesions on parkinsonian signs, striatal dopamine and substantia nigra cell loss after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in monkeys: A possible role for the locus coeruleus in the progression of Parkinson's disease
38. Ibedenone attenuates neuronal degeneration induced by striatal injection of excitotoxins
39. Glutamate becomes neurotoxic via the N-methyl-D-aspartate receptor when intracellular energy levels are reduced
40. Taurine as osmoregulator and neuromodulator in the brain
41. Excitotoxic amino acids and neuropsychiatric disorders
42. Nerve growth factor and basic fibroblast growth factor protect cholinergic neurons against quinolinic acid excitotoxicity in the rat neostriatum
43. 3H]RX821002-labeled rat Ralpha2A adrenergic receptors in cerebral cortex to human Halpha2A adrenergic receptor and other populations of α-2 adrenergic subtypes
44. Effects of methylmercury on the spontaneous and potassium-evoked release of endogenous amino acids from cerebellar slices
45. Excitotoxicity and the NMDA receptor - Still lethal after eight years
46. The evidence for astrocytes as a target for central noradrenergic activity: Expression of adrenergic receptors
47. II. Excitotoxic models for neurodegenerative disorders
48. Beta-adrenergic regulation, through cyclic AMP, of nerve growth factor expression in rat cortical and cerebellar astrocytes
49. Are glial cells targets of the central noradrenergic system? A review of the evidence
50. Effect of yohimbine on nerve growth factor mRNA and protein levels in rat hippocampus
51. Neuropharmacology of quinolinic and kynurenic acids
52. Behavioral evaluation of the anti-excitotoxic properties of MK-801: Comparison with neurochemical measurements
53. Metabolic coupling between glia and neurons
54. Towards an understanding of glutamate in neuro-degenerative disorders: Energy metabolism and neuropathology
55. Alpha2-adrenoceptors modulate NMDA-evoked responses of neurons in superficial and deeper dorsal horn of the medulla